Commercial blot assays in the diagnosis of systemic rheumatic diseases
Ghirardello A et al. - They actually represent an important step-forward in the methodological panorama designed for the autoimmunity laboratory. However continuous effort in order to validate and improve clinical reliability of commercially available blot assays should be carried out. Preliminary contribution on the validation of a commercial line blot assay for the laboratory diagnosis of autoimmune myositis is briefly reported. [more...]
|
|
|
